Putting faces to members I have known online for a long time
The organizers of this conference have been kind enough to invite me to speak. I was unable to accept their invitation last year. I did not want to drag my husband PC to conferences and I certainly did not want to spend a single day away from him. Sadly enough, I have no such constraints on my time now. I hope I get a chance to meet many of you.
Incidentally, my speaking slot is not as a dinner time speaker on Friday. I will be speaking instead on Saturday, April 25 during the Patient Session. I will try my best to make it an interesting speech, hopefully it will get some discussion going.
2nd TRENDS IN TREATING CLL Conference
April 24-26, 2009, Niagara Falls, Ontario
Sheraton Fallsview Hotel and Conference Center
Co-hosted by CLL Patient Advocacy Group, Juravinski Cancer Centre and The Leukemia & Lymphoma Society of Canada
This conference is the brainchild of the CLL Patient Advocacy Group and is intended for CLL Patients/Family and Friends, as well as Healthcare Professionals. This conference is a follow-up to the first conference held in 2007.
The explosion of new therapeutic drug research worldwide and sophisticated prognostic tools has significantly improved the treatment of CLL patients. Those who want to make a real difference in diagnosis and treatment to improve quality and possible extension of life have developed “Trends in Treating CLL” on behalf of all people living with CLL who cope with this incurable and devastating disease.
Our special thanks to Dr. Ronan Foley, MD, FRCPC, for chairing this conference. Dr. Foley is a clinical hematologist at the Jurvinski Cancer Centre, Director of the Stem Cell Laboratory and Chair of the Clinical Trials Network of the Canadian Bone Marrow Transplant Group (CBMTG), as well as an Associate Professor of Pathology and Molecular Medicine at McMaster University.
We are anticipating over 300 attendees! To register, please fill out the registration form below or call 1 (866) 585-2873.
SCIENTIFIC SESSION: Friday, April 24 10:00 am – 5:00 pm
For healthcare professionals and interested patients. This session eligible for CME accreditation.
Agenda (lunch provided)
1. Dr. David Spaner – Biology of CLL
2. Dr. Neil Kay – Prognostic Markers
3. Dr. Spencer Gibson – Canadian Biomarker and Tumour Bank Initiatives
4. Dr. Joseph Flynn – How to Best Use New Drugs in B-CLL
5. Dr. Bill Weirda – New Therapies
6. Dr. Brian Leber – Allogenic Transplants
7. Dr. Graham Fraser – Clinical Trials
8. Dr. Shelly Gunn – Genome Testing with HemeScan
9. Dr. Bill Evans – The Cancer Drug Approval Process in Ontario
10. Panel Discussion – Challenging Cases From Audience
Friday Evening Dinner: Speakers: Dr. Chaya Venkat and Dr. Brian Koffman
PATIENT SESSION: Saturday, April 25 9:00 am – 4:00 pm
For patients, family, friends and interested healthcare professionals.
Agenda (breakfast & lunch provided)
1. Dr. Neil Kay – Prognostic Markers for Patients
2. Dr. Ronan Foley – Current B-CLL Therapy in Ontario
3. Dr. Joseph Flynn – What About New Drugs?
4. Dr. Bill Weirda – What About New Drugs?
5. Dr. Spencer Gibson – Tumour Bank
6. Dr. Susan Leclair – Understanding Blood Work
7. Dave Thomas – My Journey, Patient Advocacy
8. Panel Discussion – Questions From Audience
Sunday Breakfast For Patients, Family & Friends: 8:30 am
This conference is provided free of charge to patients and caregivers. If you would like to make a donation to support our efforts, please click here. When entering your donation, please select ‘CLL Conference’ from the Fund/Designation drop-down menu.